Jay Hancock

Jay Hancock was a senior correspondent for KFF Health News until he retired in Feburary 2022.

jayhancock@protonmail.com
@JayHancock1

Covid Expert Joins Exodus Into Business, Where Science Parlays Into Profits

KFF Health News Original

Like others in academia or government who’ve served as public health advisers during the pandemic, Dr. Michael Mina traded his university role for a commercial venture. He recently took a top job at eMed, a startup that charges a premium price for monitoring at-home covid tests. Can experts do well by trying to do good?

An $80,000 Tab for Newborns Lays Out a Loophole in the New Law to Curb Surprise Bills

KFF Health News Original

The insurance company said that the birth of the Bull family’s twins was not an emergency and that NICU care was “not medically necessary.” The family’s experience with a huge bill sent to collections happened in 2020, but it exposes a hole in the new No Surprises law that took effect Jan. 1.

Pfizer Court Fight Could Legalize Medicare Copays and Unleash ‘Gold Rush’ in Sales

KFF Health News Original

Pharmaceutical companies routinely cover the cost of patient copays for expensive drugs under private insurance. A federal judge could make the practice legal for millions on Medicare as well.

In Alleged Health Care ‘Money Grab,’ Nation’s Largest Hospital Chain Cashes In on Trauma Centers

KFF Health News Original

HCA charges patients an “activation fee” of up to $50,000 for trauma teams at centers located in half its 179 hospitals — and they often don’t need trauma care, an analysis of insurance claims data shows.

Covid Testing Has Turned Into a Financial Windfall for Hospitals and Other Providers

KFF Health News Original

Because there are no caps on cost, consumers and insurers often get billed hundreds of dollars for the most reliable PCR covid test. Prices are rising and they can’t fight back.

Por qué ni siquiera la presión presidencial podría acelerar las vacunas contra covid

KFF Health News Original

Miles de estadounidenses están muriendo a causa de covid-19, pero los esfuerzos para aumentar la producción de vacunas que potencialmente salvan vidas están en un callejón sin salida.

Inside the First Chaotic Days of the Effort to Vaccinate America

KFF Health News Original

After missteps in Washington, each state and county is left to juggle where to send vaccines first and how to get them to each nursing home, hospital local health department and even school.

UVA Health Still Squeezing Money From Patients — By Seizing Their Home Equity

KFF Health News Original

The University of Virginia promised reforms but has stopped short of announcing them, while hospital giant VCU Health has freed tens of thousands from property liens.

COVID-19: las farmacéuticas elogiadas por Trump mandan dinero a Biden

KFF Health News Original

Revirtiendo una tendencia en las contribuciones de las farmacéuticas, que enviaban mucho dinero a los republicanos, en lo que va de 2020 la industria se ha inclinado hacia los demócratas.

As Trump Touts His ‘Great’ COVID Drugs, the Pharma Cash Flows to Biden, Not Him

KFF Health News Original

President Donald Trump has been heralding drugmakers as “great companies.” Yet in the final stretch of the presidential campaign, Trump is not feeling the love in pharma contributions. Former Vice President Joe Biden is, even though his proposed policies could dent the industry’s profitability.